Search results for: Market Access
Filter search results
Donor Investment Choices: Modeling the Value for Money of Investing in Product Development, Public Private Parnerships as Compared to Other Health Care and Non-Health Care Interventions
1 December 2006
Objective To model the cost-effectiveness for donors of investing in R&D projects into global diseases via public private partnerships for product development (PD PPPs). Methods We modelled the R&D process…
Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance
1 November 2006
This Annual Lecture took place on the 10 November 2005 at the Royal College of Physicians and was presented by Kenneth Arrow and Richard Peto.… This Annual Lecture took place…
Immunisation for Everyone – The Polio Experience
1 September 1979
In the richer nations of Europe and North America the gaining of control over the common infectious illnesses was a long, gradual process. It was initiated by improvements in the…
Medicines, Health and the Poor World
1 April 1982
In 1972 the Office of Health Economics produced a paper entitled Medical Care in Developing Countries. Drawing on both information available within the pharmaceutical industry and the writings of commentators…
Costs and Benefits of Regulating New Product Development in the UK Pharmaceutical Industry
3 January 1982
…the survey was carried out in 1980 there has been some relaxation of the regulations controlling the testing and marketing of new medicines. In particular, the delays to clinical trials…
Patterns of European Diagnoses and Prescribing
1 January 1984
…prescribing doctors conducted quarterly by the market research agency IMS International – known as Intercontinental Medical Statistics in the UK (see Appendix A). After an initial discussion of the aims…
Aids in Africa: Meeting the Challenge through Training Education and Prevention
1 January 1992
AIDS poses a formidable challenge to African policy makers and health professionals. Of the estimated 9 to 11 million cases of HIV infection worldwide, some 7 million are in sub-Saharan…
Health Care as a Handicraft Industry
9 January 1995
…Many of his points will give pause for thought to those on both sides of the UK debate about the NHS internal market. He suggests that information, choice and competition…
Industrial Policy and the Pharmaceutical Industry
1 January 1995
…are responsible for both ‘health and safety’ and ‘economic’ regulation. The former primarily governs the licensing procedures before a new medicine can be put on the market. The latter has…